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Research
Studies of human populations show that 
ambient particulate matter (PM) air pollu-
tion is associated with coronary heart dis-
ease (CHD) morbidity and mortality. The 
consistent findings suggest direct associations 
between both short- and long-term exposure 
to PM and CHD incident [Brook et al. 2004; 
Dockery et al. 1993; Miller et al. 2007; Pope 
et al. 2006; U.S. Environmental Protection 
Agency (EPA) 2006]. However, biologi-
cal mechanisms underlying the association 
between PM and CHD remain incompletely 
characterized in human populations despite 
calls for epidemiologic research designed 
to help elucidate them (Brook et al. 2004; 
Health Effects Institute 2002; National 
Research Council 2004).
Resting, supine, standard 12-lead electro-
cardiography (ECG) has been recognized as a 
potentially valuable epidemiologic tool in this 
regard, yet to date much of its value remains 
unrealized. ECG findings characteristic of 
myocardial ischemia, for example, have not 
been adequately evaluated in this context. 
These measures include ST-segment depres-
sion and T-wave inversion on the ECG.
Because of their clinical value, these ECG 
findings have also attracted environmental, 
toxicologic, and epidemiologic interest. Indeed, 
they are thought to be relevant in studies focus-
ing on arrhythmogenic effects of air pollution 
(Zareba et al. 2001) and risk factors for sudden 
death due to cardiac arrhythmia (Huikuri et al. 
2001). The literature in this area has never-
theless focused on experimentation in animal 
models of coronary vasoconstriction (Campen 
et al. 2005; Godleski et al. 2000; Nikolov et al. 
2007; Wellenius et al. 2003) or examination 
of typically small, single-city panels of CHD-
burdened, Holter-monitored male participants 
during exercise (Gold et al. 2005; Henneberger 
et al. 2005; Lanki et al. 2006; Mills et al. 2007; 
Pekkanen et al. 2002; Yue et al. 2007). For 
this reason, epidemiologic evidence linking PM 
exposure to minor but prognostically important 
abnormalities of the ST segment and T wave in 
human populations at rest is quite limited.
We therefore designed the present study 
to investigate the association between acute 
exposures to ambient PM < 2.5 µm in diam-
eter (PM2.5) and ECG measures of myocardial 
ischemia in a relatively large, geographically 
diverse, healthy female population enrolled 
in the Women’s Health Initiative (WHI) 
clinical trials.
Methods
Study design. We examined the associa  tion 
between PM2.5 and ischemia in the Environ-
mental Epidemiology of Arrhythmogenesis in 
WHI (EEAWHI) study, an ancillary study of 
proarrhythmic mechanisms linking air pollu-
tion and CHD among 68,133 WHI clinical 
trial participants examined at 49 sites. The 
WHI clinical trial is a multi  center study of 
risk factors for prevention of common causes 
of mortality, morbidity, and impaired qual-
ity of life in U.S. post  menopausal women. 
Details of the study design, including recruit-
ment procedures and selection and exclusion 
criteria, have been published elsewhere (WHI 
Study Group 1998). The study was approved 
by each study site’s institutional review board. 
All participants provided written informed 
consent.
Study population. Of the 68,133 WHI 
clinical trial participants at baseline, we 
excluded 2,082 (3.1%) with foreign, U.S. mili-
tary, U.S. protectorate, Hawaiian, Alaskan, or 
missing addresses; 417 (0.6%) with missing or 
poor-quality ECGs; 2,379 (3.5%) with ECG 
QRS duration ≥ 120 msec; and 7,726 (11%) 
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Ba c k g r o u n d: Ambient particulate matter (PM) air pollution is associated with coronary heart 
  disease, but the pathways underlying the association remain to be elucidated.
Me t h o d s : We studied the association between PM and ischemia among 57,908 Women’s Health 
Initiative clinical trial participants from 1999–2003. We used the Minnesota Code criteria to 
identify ST-segment and T-wave abnormalities, and estimated T amplitude (microvolt) from 
resting, standard 12-lead electrocardiogram (ECG). We used U.S. Environmental Protection 
Agency’s monitor data to estimate concentrations of PM < 2.5 µm (PM2.5) at geocoded participant 
addresses over 6 days before the ECGs (lag0 through lag5). We excluded 2,379 women with ECG 
QRS duration ≥ 120 msec.
re s u l t s: Overall, 6% of the remaining 55,529 women (52–90 years of age; 83% non-Hispanic 
white) had ST abnormalities and 16% had T abnormalities. Lead-specific T amplitude was nor-
mally distributed (range of means from –14 to 349 µV). PM2.5 (mean ± SD) averaged over lag0–2 
was 14 ± 7 µg/m3. In logistic and linear regression models adjusted for demographic, clinical, tem-
poral, and climatic factors, a 10-µg/m3 increase in lag0–2 PM2.5 was associated with a 4% [95% con-
fidence interval (CI), –3%, to 10%] increase in the odds of ST abnormality and a 5% (95% CI, 0% 
to 9%) increase in the odds of T abnormality. We observed corresponding decreases in T amplitude 
in all exam sites and leads except lead V1, reaching a minimum of –2 µV (95% CI, –5 to 0 µV) in 
lead V3.
co n c l u s i o n s: Short-term PM2.5 exposure is associated with ECG evidence of myocardial ischemia 
among postmenopausal women. The principal manifestations include subclinical but potentially 
arrhythmogenic ST–T abnormalities and decreases in T amplitude.
key w o r d s : air pollution, cardiovascular disease, electrocardiography, myocardial ischemia, particu-
late matter. Environ Health Perspect 117:751–756 (2009).  doi:10.1289/ehp.0800046 available via 
http://dx.doi.org/ [Online 23 January 2009]Zhang et al.
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without an ECG recording between 1999 and 
2003, the initial 5-year period in which PM2.5 
data were routinely collected by the U.S. EPA 
Air Quality System (AQS). The present study 
focuses on the initial high-quality, resting, stan-
dard 12-lead ECGs recorded during this period 
among the remaining 55,529 participants, 
all of whom had addresses in the contiguous 
United States.
ECG methodology. Identical ECGs (MAC 
PC, Marquette Electronics, Inc., Milwaukee, 
WI) were used in all clinic sites, and resting, 
standard 12-lead ECGs were recorded for all 
participants using strictly standardized pro-
cedures. The chest electrodes were located in 
precise positions. All ECGs were processed in 
a central ECG laboratory (Epidemiological 
Cardiology Research Center, Wake Forest 
University, Winston-Salem, NC), where they 
were visually inspected for technical errors and 
inadequate quality. The ECGs were initially 
processed with the Dalhousie ECG program, 
and for the present study we reprocessed them 
with the 2001 version of the GE Marquette 
12-SL program (GE Healthcare 2008; Prineas 
et al. 1982; Rautaharju et al. 1998). The 
Marquette measurement matrix contained sev-
eral ECG measures of myocardial ischemia that 
we used as outcome variables in this study.
ST-segment and T-wave amplitudes 
(microvolt). We defined lead-specific depth 
(or height) of the ST segment (ST) 60 msec 
after the J point and T-wave amplitude (T) 
relative to the isoelectric line.
ST, T, and ST–T abnormalities. We 
applied Minnesota Code (MC) criteria to the 
former interval-scale measures to identify ST 
abnormality (MC 4.1–4.4), T abnormality 
(MC 5.1–5.4), or any ST–T abnormality (MC 
4.1–4.4 or MC 5.1–5.4) (Prineas et al. 1982).
QRS/T angles (degrees). The frontal 
plane QRS/T angle was defined as the abso-
lute value of the difference between the frontal 
plane QRS and T axes (range, –89° to 270°). 
When > 180°, it was adjusted to the minimal 
angle as follows: 360° – frontal plane QRS/T 
angle (Zhang et al. 2007). We defined the 
spatial QRS/T angle as the angle between the 
mean QRS and T vectors, which we calcu-
lated from quasi-orthogonal X, Y, and Z leads 
reconstructed from the standard ECG leads 
via matrix transformation (Rautaharju et al. 
2006b).
Air pollutant concentrations, weather vari-
ables, and other participant characteristics. 
We obtained all ambient PM2.5 concentra-
tion data recorded at monitors operating in 
the contiguous United States during the study 
from the U.S. EPA AQS. The data included 
the longitude and latitude of each monitor. 
We used a semiautomated program built on 
ArcView GIS (version 8.3) software and its 
Geostatistical Analyst extension (ESRI, Inc. 
Redlands, CA) to produce kriging-estimated 
daily mean concentrations (and their SEs) 
at each geocoded participant and exam site 
address from the baseline examination through 
2004 (Liao et al. 2006, 2007; Whitsel et al. 
2006). The program relied on a spherical 
model to perform national-scale, lognormal 
ordinary kriging and the weighted least-squares 
method to estimate semivariograms, and ran 
and cross-validated each daily semivariogram. 
From the kriging-estimated, daily mean, loca-
tion-specific PM2.5 concentrations, we then 
computed a matrix of 15 short-term pollut-
ant exposures by averaging within over-
lapping 1-, 2-, and 3-day lag combinations 
inside a 6-day exposure window beginning   
5 days before and ending on the examination 
date, that is, days 0–5. Associations between 
PM and ischemia were strongest on days 0–2 
(lag0–2), the emphasis of the present report.
We obtained all meteorologic data 
recorded at relevant stations and times from 
the National Climatic Data Center (U.S. 
National Climatic Data Center 2007): ambi-
ent temperature (degrees centigrade), dew 
point (degrees centigrade), and barometric 
pressures (kilo pascal), as well as station lon-
gitudes, latitudes, and altitudes. Daily mean 
temperature, dew point, and pressure at each 
geocoded participant and exam site address 
from baseline to closeout were estimated by 
averaging daily means across all stations within 
50 km, a distance over which their station-
to-station correlations exceed 0.90 (Ito et al. 
2001). Thereafter, we computed weather 
variables at lag0–2/lag3–5 as described above 
for PM2.5.
Self-reported education, medication use, 
health history, and a variety of other attributes 
were determined at each visit by standardized 
participant interview and examination by the 
WHI staff. Interim health events were iden-
tified via standardized medical record review 
and physician adjudication. Specifically, diabe-
tes was defined by antidiabetic medication use 
or history; hypertension by antihypertensive 
medication use, systolic blood pressure (SBP) 
≥ 140 mmHg, diastolic blood pressure (DBP) 
≥ 90 mmHg, or history; body mass index 
(BMI) as the ratio of weight (kilograms) to 
height (square meters); hypercholesterolemia by 
antihyperlipidemic medication use or history; 
smoking as current, former, or never; chronic 
lung disease by history of asthma, emphysema, 
or lung cancer; CHD by antianginal medica-
tion use, history of angina, or myocardial infarc-
tion and medical record review/adjudication; 
revascularization by history of coronary artery 
angioplasty, stent, or bypass and medical record 
review/adjudication; and congestive heart fail-
ure by cardiac glycoside/diuretic use, history, 
and medical record review/adjudication.
Statistical analysis methods. We inspected 
frequency distributions of all variables for out-
liers but did not identify influential values. 
Table 1. The demographic and clinical char  ac-
teristics of the study population on the date of ECG 
examination (n = 55,529).
Characteristic  Mean ± SD or percent
Age in years on ECG exam date  67 ± 7
Race
  White  83
  Black  10
  Other  7
Education < college  23
BMI (kg/m2 )  29 ± 6
SBP (mmHg)  126 ± 17
DBP (mmHg)  73 ± 9
Hypertension  52
Hypercholesterolemia  20
Diabetes  8
Current smoking  6
CHDa  11
Chronic lung disease  10
Beta-blocker use  13
Exam season
  Spring  27
  Summer  26
  Fall  25
  Winter  22
Exam day
  Monday–Thursday  86
  Friday  12
  Saturday–Sunday  2
Exam time
  Morning  64
  Afternoon  36
aCHD includes congestive heart failure, coronary revas-
cularization, or myocardial infarction by Minnesota Code 
or Novacode.
Table 2. The ECG parameters  of  the  study 
population  on  the  date  of  ECG  examination   
(n = 55,529). 
ECG parameter  Mean ± SD or percent
Minnesota codes
  MC 4a 6
  MC 5b  16
  MC 4 or MC 5c  18
T-wave amplitude (µV)
  Lead I  202 ± 105
  Lead II  241 ± 105
  Lead aVL  86 ± 93
  Lead V1  –14 ± 116
  Lead V2  313 ± 197
  Lead V3  349 ± 203
  Lead V4  324 ± 193
  Lead V5  284 ± 167
  Lead V6  221 ± 126
ST-segment amplitude (µV)
  Lead I  13 ± 21
  Lead II  19 ± 25
  Lead aVL  4 ± 17
  Lead V1  27 ± 27
  Lead V2  64 ± 46
  Lead V3  47 ± 41
  Lead V4  29 ± 35
  Lead V5  18 ± 29
  Lead V6  11 ± 23
QRS/T angles and heart rate
  Heart rate (beats/min)  66 ± 10
  QRS/T angle–spatial (°)  60 ± 28
  QRS/T angle–frontal plane (°)  29 ± 27
aAny ST abnormality (MC 4.1–4.4). bAny T abnormal- ny T abnormal-
ity (MC 5.1–5.4).cAny ST–T abnormality (MC 4.1–4.4 or 
MC 5.1–5.4).PM2.5 and myocardial ischemia
Environmental Health Perspectives  •  v o l u m e  117 | n u m b e r 5 | May 2009  753
Initially ignoring the influences of exam site, 
we explored the associations between ischemia 
and PM2.5 in unadjusted linear and logistic 
regression models. To control for residual con-
founding by exam season, day of week, time 
of day, health, and weather, we added tempo-
ral, demographic, clinical, and meteorologic 
charac  teristics to the models. We then con-
ducted hierarchical analyses in two stages. In 
the first stage we used site-specific, adjusted 
regression models to estimate strength of the 
ischemia–PM2.5 associations. The models 
allowed these estimates to vary among sites. 
In the second stage we used random effects 
meta-regression of the site-specific, linear 
regression coefficients from the first stage to 
estimate overall strength of the ischemia–PM 
associations across sites. These weighted, itera-
tive regression models allowed for an additive, 
between-study component of residual variance 
estimated via restricted maximum likelihood 
(Berkey et al. 1995). We repeated the second-
stage analyses by placing uninformative priors 
on the second-stage parameters and Monte 
Carlo sampling from the conditional distribu-
tion of each unknown using standard Bayesian 
hierarchical regression algorithms (Robert 
and Casella 2004). We evaluated effect meas-
ure modification by including cross-product 
terms for the interaction between PM2.5 and 
CHD and its major risk factors at the first 
stage. Analyses based on logistic and linear 
regression models adjusting for exam site, and 
both the random-effects meta-analyses and 
Bayesian hierarchical regression analyses of the 
adjusted, site-specific regression coefficients 
produced similar results. We conducted all 
analyses using SAS version 9.1 (SAS Institute, 
Inc., Cary, NC) and MATLAB, version 7.0, 
software (MathWorks, Inc., Natick, MA). By 
convention, we report resulting estimates as 
odds ratios for ST, T, and ST–T abnormali-
ties, or microvolt (µV) changes in ST-segment 
and T-wave amplitudes associated with   
10 µg/m3 increases in PM2.5 concentrations.
Results
Of the 55,529 female participants (age range, 
52–90 years), 83% were non-Hispanic 
white, 52% hypertensive, and 20% hyper-
cholesterolemia (Table 1). Somewhat smaller 
percentages were current smokers (6%) or 
had diabetes (8%), CHD (11%), or chronic 
lung disease (10%). Six percent of the study 
population had ST abnormalities, and 16% 
had T abnormalities. Lead-specific ST and 
T amplitudes were normally distributed 
(range of means = 4, 64 µV and –14, 349 µV, 
respectively). Mean ± SD spatial and fron-
tal plane QRS/T angles were 60° ± 28° and 
29° ± 27°, with heart rate 66 ± 10 beats/min 
(Table 2). Mean PM2.5 averaged over the first 
3 days and second 3 days preceding the ECG 
(lag0–2 and lag3–5) were equivalent, as were 
mean temperature, dew point, and barometric 
pressure (Table 3).
In logistic and linear regression models 
adjusted for demographic, clinical, tempo-
ral, and climatic factors, 10 µg/m3 increases 
in lag0–2 PM2.5 were associated with 4–5% 
increases in odds ratios (ORs) for ST, T, 
and ST–T abnormalities, small decreases in 
lead-specific ST and T amplitudes, and slight 
increases in the QRS/T angles and heart 
rate (Table 4). We observed decreases in T 
amplitude in all leads except V1, reaching a 
minimum of –2.3 µV [95% confidence inter-
val (CI), –5.2 to 0.5 µV] in lead V3 even 
after controlling for its reported dependence 
on heart rate (Couderc et al. 2007). These 
observations were consistent across exam sites 
(Figure 1). The observed magnitude and direc-
tion of effects associated with lag3–5 PM2.5 
were often weaker and less consistent [Table 4 
and Supplemental Material, Tables 1 and 2 
(available online at http://www.ehponline.   
org/members/2009/0800046/suppl.pdf)]. 
Findings based on unadjusted models and 
those controlling for randomization status as 
well as additional participant- and contextual- 
level measures of education, occupation, 
income, and housing were comparable.
Effects of lag0–2 PM2.5 were slightly 
stronger among users versus nonusers of 
beta-blockers: 10% (1%, 20%) versus 3% 
(–1%, 8%) increases in the odds of T abnor-
mality (p = 0.098) and –8 (–15, –1) versus 
–2 (–4, 1) µV decreases in T amplitude in lead 
V3 (p = 0.076), but in general, there was little 
suggestion of effect measure modification by 
CHD or its major risk factors.
Discussion
Judging from the U.S. EPA’s Provisional 
Assessment of Recent Studies on Health Effects 
of Particulate Matter Exposure (National 
Center for Environmental Assessment 
2006), interest in subclinical, atherosclerotic 
manifestations of long-term ambient PM2.5 
exposure has dramatically increased. Indeed, 
Table 3. PM concentrations and weather vari-
ables for the study population on the date of ECG 
examination.
Characteristic   Mean ± SD
PM2.5
a
  Lag0  14.1 ± 8
  Lag1  13.8 ± 8
  Lag2  13.8 ± 8
  Lag3  13.8 ± 8
  Lag4  13.9 ± 8
  Lag5  14.1 ± 8
  Lag0–2
b  13.9 ± 7
Weather
  Temperature lag0–2
b  13.9 ± 9
  Dew point lag0–2
b  7.6 ± 9
  Barometric pressure lag0–2
b  102 ± 1
aConcentrations at geocoded participant addresses on 
day of exam (lag0) and preceding 5 days (lag1–5). bThe 
mean ± SD for PM2.5 and weather variables were the same 
at lag3–5.
Table 4. Multivariable-adjusteda ORs and changes (95% CI) per 10-µg/m3 increase in PM2.5.
ECG parameter   Lag0–2 (95% CI)  Lag3–5 (95% CI)
Minnesota Codes (OR)
  MC 4b  1.04 (0.97 to 1.10)  1.04 (0.98 to 1.11)
  MC 5c  1.05 (1.00 to 1.09)  1.04 (1.00 to 1.08)
  MC 4 or MC 5d  1.04 (1.00 to 1.09)  1.03 (0.99 to 1.07)
ST-segment amplitude (µV, change)
  Lead I  –0.07 (–0.36 to 0.21)   0.18 (–0.10 to 0.46)
  Lead II  –0.12 (–0.47 to 0.23)   0.16 (–0.18 to 0.50)
  Lead aVL  –0.01 (–0.25 to 0.23)   0.11 (–0.12 to 0.34)
  Lead V1  –0.02 (–0.39 to 0.35)  –0.22 (–0.58 to 0.14)
  Lead V2   0.07 (–0.57 to 0.70)  –0.01 (–0.61 to 0.62)
  Lead V3  –0.11 (–0.68 to 0.47)  –0.02 (–0.58 to 0.54)
  Lead V4  –0.03 (–0.51 to 0.45)   0.24 (–0.23 to 0.71)
  Lead V5  –0.01 (–0.41 to 0.39)   0.35 (–0.04 to 0.74)
  Lead V6  0.02 (–0.30 to 0.33)   0.35 ( 0.04 to 0.65)
T-wave amplitude (µV, change)
  Lead I  –1.60 (–3.07 to –0.13)  –0.31 (–1.73 to 1.11)
  Lead II  –0.54 (–1.99 to 0.92)   0.71 (–0.70 to 2.13)
  Lead aVL  –1.21 (–2.50 to 0.10)  –0.55 (–1.81 to 0.71)
  Lead V1   1.45 (–0.16 to 3.06)   0.03 (–1.53 to 1.59)
  Lead V2  –0.18 (–2.96 to 2.60)   0.57 (–2.12 to 3.27)
  Lead V3  –2.33 (–5.15 to 0.49)  –0.13 (–2.87 to 2.60)
  Lead V4  –2.03 (–4.69 to 0.63)   0.64 (–1.94 to 3.22)
  Lead V5  –1.92 (–4.22 to 0.38)   0.55 (–1.69 to 2.78)
  Lead V6  –0.63 (–2.36 to 1.10)   0.82 (–0.86 to 2.49)
QRS/T angles and heart rate (change)
  QRS/T angle–spatial (°)   0.19 (–0.21 to 0.59)  –0.20 (–0.59 to 0.19)
  QRS/T angle–frontal plane (°)   0.13 (–0.24 to 0.50)   0.35 (–0.01 to 0.71)
  Heart rate (beats/min)   0.16 ( 0.02 to 0.30)   0.04 (–0.10 to 0.18)
aEstimates based on logistic and linear regression models adjusted for demographic, clinical, and weather variables: age; 
race/ethnicity; education; exam site; BMI; current smoking status; history of CHD, diabetes, hypertension, SBP, chronic 
lung disease, or hypercholesterolemia; day of week; time of day; temperature; dew point; pressure and season; bAny ST 
abnormality (MC 4.1–4.4). cAny T abnormality (MC 5.1–5.4). dAny ST–T abnormality (MC 4.1–4.4 or MC 5.1–5.4).Zhang et al.
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the July 2006 assessment included only one 
such study (of coronary artery calcium), yet 
in the interim, several others have also exam-
ined associations between PM2.5 exposures 
sustained over months to years and nonin-
vasive measures of atherosclerosis, including 
carotid intimal-medial thickness, abdominal 
aortic calcification, and ankle-brachial index 
(Allen et al. 2009; Diez Roux et al. 2008; 
Hoffmann et al. 2007; Kunzli et al. 2005). 
The epidemiologic associations observed in 
these studies are not entirely consistent with 
one another or collectively as strong as those 
that may have been anticipated on the basis 
of recently reported associations between 
chronic PM exposure and cardiovascular dis-
ease (e.g., Miller et al. 2007), and the role of 
atherosclerotic mechanisms in the associa-
tion remains uncertain.
We examined the role of acute, ischemic 
mechanisms in the association between PM2.5 
and CHD among WHI clinical trial partic-
ipants with this uncertainty in mind, using 
ECG—a simple, noninvasive, and underused 
research tool. In this epidemiologic context, 
however, we did not limit the examination to 
characteristics of clinically manifest ischemia 
(e.g., ≥ 0.1 mV of downsloping ST segment 
depression and/or deep, symmetrical, pre-
cordial T-wave inversion). We opted instead 
to include minor abnormalities of ventricu-
lar repolarization (ST–T abnormalities, ST 
and T amplitudes) and depolarization (QRS/T 
angles) to increase sensitivity of the ECG for 
sub  clinical forms of myocardial ischemia. 
Using this tool, we found that a 10 µg/m3 
increment in lag0–2 PM2.5 is associated with 
4–5% increased odds of minor ST, T, and 
ST–T abnormalities, small decreases in ST and 
T amplitudes across most leads and exam sites, 
and corresponding increases in QRS/T angles.
Previous findings from the WHI clinical 
trials cohort include significant prospective 
relationships between isolated ST–T abnor-
malities, lead-specific ST and T amplitudes, 
and wide QRS/T angle at baseline, and CHD 
mortality, incident CHD, and congestive heart 
failure (Rautaharju et al. 2006b). Similar find-
ings also have been described in population-
based settings, such as the Atherosclerosis Risk 
in Communities study (Zhang et al. 2007), 
Cardiovascular Health Study (Rautaharju et al. 
2006a), and Chicago Western Electric Study 
(Daviglus et al. 1999), among others (Engel 
et al. 2004; Larsen et al. 2002; Okin et al. 
2005, 2007; Schouten et al. 1992). However, 
the clinical utility of these ECG measures 
remains limited.
Considering the consistent associations 
between PM2.5 and the ECG measures of 
myocardial ischemia observed in this context 
and the established, prospective association of 
these measures with CHD, the findings from 
the present study provide additional support 
for the hypothesis that subclinical myocardial 
ischemia has a pathophysiologic role in the 
adverse effects of acute exposure to PM2.5 on 
the heart, including predisposition to ven-
tricular arrhythmogenesis and sudden cardiac 
death (Rubart and Zipes 2005). This is the first 
study to examine such an association in a large 
popu  lation of postmenopausal women. Indeed, 
prior studies have focused on either animal 
models of coronary vasoconstriction (Campen 
et al. 2005; Godleski et al. 2000; Nikolov et al. 
2007; Wellenius et al. 2003) or typically small, 
single-city panels of CHD-burdened, Holter-
monitored male participants during exercise 
(Gold et al. 2005; Henneberger et al. 2005; 
Lanki et al. 2006; Mills et al. 2007; Pekkanen 
et al. 2002; Yue et al. 2007) (Table 5). The 
findings described herein are nonetheless con-
sistent with and thereby extend the findings 
previously described in these populations. They 
do not imply, however, that ischemia is the 
sole process by which PM2.5 exerts its adverse 
effects on the heart. Autonomic, thrombotic, 
endothelial, inflammatory, oxidative, and other 
mechanisms of disease have all been implicated 
in cardiovascular effects of PM (Chuang et al. 
2007; Mills et al. 2007).
This study has several limitations that may 
affect interpretation of its findings. First, it is 
an ancillary study of participants in the WHI 
clinical trials. Inference is therefore limited to 
postmenopausal women 52–90 years of age liv-
ing in the contiguous 48 United States between 
1999 and 2003, the initial 5-year period dur-
ing which PM2.5 data were routinely collected 
by the U.S. EPA AQS. Because women in 
the WHI clinical trials were randomized to 
estrogen with or without progestin treatment, 
Table 5. Human studies of association of PM and ischemia.
     Mean age      Detection
Reference   No.  Location  (years)  Female (%)  Outcomes  method
Pekkanen et al. 2002  45  Helsinki, Finland  68  47  STD  E Holter
Henneberger et al. 2005  56  Efurt, Germany  66  0  TWA  R Holter
Gold et al. 2005  24  Boston, MA, USA  73  75  STD  E Holter
Lanki et al. 2006  45  Helsinki, Finland  68  47  STD  E Holter
Yue et al. 2007  56  Efurt, Germany  66  0  TWA  R Holter
Mills et al. 2007  20  Southampton, UK  60  0  STD  E Holter
Zhang et al. 2008  55,529  49 exam sitesa  67  100  STT, STA, TWA  Resting ECG
Abbreviations: E, exercise; R, rest; STA, ST-segment amplitude; STD, ST-segment depression; STT, ST-segment and 
T-wave abnormalities; TWA, T-wave amplitude. ECG involved resting, supine, standard 12-lead ECG.
aIn the contiguous United States. 
Figure 1. Multivariable-adjusted ORs for ST–T abnormality and changes in T amplitude (µV) in lead 
V3 (95% CI) per 10-µg/m3 increase in lag0–2 PM2.5, by exam site. We based estimates on Bayesian 
hierarchical regression models adjusted for demographic, clinical, and weather variables: age;   
race/ethnicity; education; BMI; current smoking status; history of CHD, diabetes, hypertension, SBP, 
chronic lung disease, or hypercholesterolemia; season; day of week; time of day; temperature; dew point; 
and pressure.
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calcium/vitamin D supplementation, and/or 
dietary modification, these exposures could 
have affected the ECG measures examined 
in this setting. Because ambient PM2.5 con-
centrations also decreased 11% in the United 
States between 2000 and 2007 (U.S. EPA 
2008a), observed associations between PM and 
ischemia could be weaker if this study were 
repeated today. Findings were nevertheless 
robust to adjustment for randomization status. 
Moreover, seasonally weighted annual average 
PM2.5 concentrations in the United States still 
exceed the 15 µg/m3 national ambient air qual-
ity standard at approximately 10% of trend 
sites (U.S. EPA 2008b).
Second, we did not measure PM2.5 in 
the personal breathing space of participants. 
Instead, it was spatially interpolated at each 
participant’s geocoded address, raising ques-
tions about its validity (Szpiro et al. 2007). 
Third, the associations described herein also 
may be subject to residual socioeconomic 
confounding because we defined diabetes and 
hypercholesterolemia by self-reported history 
of the disease and/or use of antihyperlipidemic 
or antidiabetic medications rather than fasting 
glucose or lipid concentrations, which were 
only available for 6% site- and race-stratified 
minority participant oversample.
In the face of these additional limitations, 
in this study we took several precautions. We 
carefully established the validity of the geo-
codes relative to criterion standards (Whitsel 
et al. 2006) and the spatial interpolations 
using standard cross-validation statistics: the 
prediction error (PE = predicted minus meas-
ured pollutant concentration at each moni-
tor site), standardized prediction error (SPE 
= PE divided by its estimated standard error), 
root mean square standardized error (RMSS 
= standard deviation of SPE across sites), root 
mean square prediction error (RMS = empiri-
cal standard error based on the mean square of 
the predictions), and mathematically calculated 
standard error (SE). Observed values of PE and 
SPE near 0 and RMSS near 1, and similarity of 
RMS and SE provide evidence of model valid-
ity (Liao et al. 2006, 2007). In addition, the 
study documented modest effects of geo  coding 
and kriging error on PM–CHD associations 
(Crooks et al. 2008; Whitsel et al. 2006). 
Finally, the study demonstrated high reliability 
of treated diabetes and hypercholesterolemia 
(Langer et al. 2003), and we adjusted effect 
sizes for additional participant- and contextual-
level measures of socio  economic status, noting 
only small changes as a result of adjustment.
Conclusion
We conclude that short-term exposure to 
PM2.5 is associated with ECG evidence of 
myocardial ischemia among postmenopausal 
women. The principal manifestations include 
ST-segment and T-wave abnormalities, 
decreases in ST segment and T amplitude, and 
increases in QRS/T angles. These findings sug-
gest that the adverse effects of PM2.5 on CHD 
risk among postmenopausal women may be 
related to its subclinical, ischemic effects on 
the myocardium.
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